2020 European Heart Valve Disease Survey
- Public awareness of heart valve disease remains low. Less than 6% of respondents knew what heart valve disease is.
- Few respondents would seek medical advice if they experienced key symptoms of aortic stenosis, suggesting that early detection opportunities could be missed
- Importantly, there continues to be inequality in stethoscope use throughout Europe and across genders. As stethoscope checks are a key initial screening method for detection of heart valve disease, this lack of consistency may leave many patients undiagnosed.
“The Survey demonstrates clearly that our older population is a key, yet underestimated, contributor to the effective functioning of our communities, families and economies, so improving the awareness, diagnosis and treatment of heart valve disease will benefit us all,” commented Wil Woan, Chair of the Heart Valve Disease Patient Council of the Global Heart Hub. “Our senior people selflessly confined themselves to protect the health of others during COVID-19; now it is time to repay them by ensuring that they receive the treatments that will transform their quality of life and lower their vulnerability to future pandemics and other significant infections.”